Versor Investments’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
CAM
RIM
Versor Investments's LMAT Position: Q3 2024 in Review
Versor Investments sold out of LeMaitre Vascular (LMAT) in Q3 2024, closing a stake of 4,700 shares — an estimated $387K sold.
Versor Investments first reported a position in LMAT in Q4 2022 and held it in 3 quarters. The position peaked at $548K in Q3 2023. 291 funds tracked by Wall St. Rank hold LMAT as of Q3 2024.
- Versor Investments reported no remaining LeMaitre Vascular position as of Q3 2024 after selling out during the quarter.
- Versor Investments sold 4,700 LeMaitre Vascular shares in Q3 2024, an estimated $387K.
- Versor Investments first reported a position in LeMaitre Vascular in Q4 2022 and held it in 3 quarters.
- Versor Investments's LeMaitre Vascular position peaked at $548K in Q3 2023.
- 291 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2024.
Based on Versor Investments's 13F filing for Q3 2024, filed 4 Nov 2024.